Corneal scars can develop due to infections, trauma or can be due to certain inherited disorders. Traditionally treatment of corneal scars has always been surgical. However, recently published studies have shown that the anti hypertensive drug – LOSARTAN has the ability to reduce corneal scar formation by inhibiting corneal stromal fibrosis. Although in its incipient phase, it seems to show great promise in treating scars, irrespective of the duration and density, thereby making it a very promising approach in the treatment of corneal scars. Patient selection is however crucial and hence a comprehensive ophthalmic exam by a corneal surgeon is mandated before undertaking treatment.